Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 4, 2015, Pages 613-621

  De Berardinis, Benedetta ^a   Gaggin, Hanna K ^b   Magrini, Laura ^a   Belcher, Arianna ^b   Zancla, Benedetta ^a   Femia, Alexandra ^b   Simon, Mandy ^b   Motiwala, Shweta ^b   Bhardwaj, Anju ^b   Parry, Blair A ^b   Nagurney, John T ^b   Coudriou, Charles ^c   Legrand, Matthieu ^c,d   Sadoune, Malha ^d   Di Somma, Salvatore ^a   Januzzi, James L ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Burn Unit   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

Author keywords

B type natriuretic peptides (BNP); cardiorenal syndrome; neutrophil gelatinase associated lipocalin (NGAL); worsening renal function

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LOOP DIURETIC AGENT; MINERALOCORTICOID ANTAGONIST; NATRIURETIC FACTOR; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SST2 PROTEIN; UNCLASSIFIED DRUG; ACUTE PHASE PROTEIN; BRAIN NATRIURETIC PEPTIDE; CELL SURFACE RECEPTOR; IL1RL1 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ACUTE HEART FAILURE; AGED; ARTICLE; BLOOD CHEMISTRY; CARDIORENAL SYNDROME; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIURETIC THERAPY; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; KIDNEY DYSFUNCTION; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; WORSENING RENAL FUNCTION; ACUTE DISEASE; AREA UNDER THE CURVE; BLOOD; BLOOD ANALYSIS; CHEMISTRY; COMPARATIVE STUDY; DISEASE COURSE; EMERGENCY HEALTH SERVICE; HEART FAILURE; KIDNEY; PATHOPHYSIOLOGY; SOLUBILITY;

ACUTE DISEASE; ACUTE-PHASE PROTEINS; AGED; AREA UNDER CURVE; BIOMARKERS; BLOOD CHEMICAL ANALYSIS; DISEASE PROGRESSION; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HUMANS; KIDNEY; LIPOCALINS; MALE; NATRIURETIC PEPTIDE, BRAIN; PATIENT ADMISSION; PEPTIDE FRAGMENTS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTORS, CELL SURFACE; ROC CURVE; SOLUBILITY;

EID: 84925710187     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0191     Document Type: Article

References (29)

1. Peacock WF, Mueller C, Disomma S, Maisel A. Emergency department perspectives on B-type natriuretic peptide utility. Congest Heart Fail 2008;14:17-20.
2. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC; ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006;47:76-84.
3. Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B, POSH Investigators. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 2006;27:1216-22.
4. Verdiani V, Lastrucci V, Nozzoli C. Worsening renal function in patients hospitalized with acute heart failure: risk factors and prognostic significances. Int J Nephrol 2011;2011:785974.
5. Damman K, Jaarsma T, Voors AA, Navis G, Hillege HL, van Veldhu-isen DJ, COACH investigators. Both in-and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). Eur J Heart Fail 2009;11:847-54.
6. Ronco C, McCullough PA, Anker SD, Anand I, Aspromonte N, Bagshaw SM, et al; Acute Dialysis Quality Initiative (ADQI) consensus group. Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2010;165:54-67.
7. Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 2002;8:136-41.
8. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-12.
9. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
10. Tang WH, Mullens W. Cardiorenal syndrome in decompensated heart failure. Heart 2010;96:255-60.
11. Murray PT, Mehta RL, Shaw A, Ronco C, Endre Z, Kellum JA, et al. Current use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int Epub 2013 Oct 9. doi:10.1038/ki.2013.374.
12. Di Somma S, Magrini L, De Berardinis B, Marino R, Ferri E, Moscatelli P, et al. Additive value of blood neutrophil gelati-nase-associated lipocalin to clinical judgement in acute kidney injury diagnosis and mortality prediction in patients hospitalized from the emergency department. Crit Care 2013;17:R29.
13. Aghel A, Shrestha K, Mullens W, Borowski A, Tang WH. Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure. J Card Fail 2010;16:49-54.
14. Maisel A, Mueller C, Adams K Jr, Anker SD, Aspromonte N, Cle-land JG, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 2008;10:824-39.
15. Bayes-Genis A, de Antonio M, Galán A, Sanz H, Urrutia A, Cabanes R, et al. Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure. Eur J Heart Fail 2012;14:32-8.
16. Pascual-Figal DA, Manzano-Fernández S, Boronat M, Casas T, Garrido IP, Bonaque JC, et al. Soluble ST2, high-sensitivity troponin T-and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail 2011;13:718-25.
17. Rehman SU, Mueller T, Januzzi JL Jr. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol 2008;52:1458-65.
18. Di Somma S, Navarin S, Giordano S, Spadini F, Lippi G, Cervellin G, et al. The emerging role of biomarkers and bio-impedance in evaluating hydration status in patients with acute heart failure. Clin Chem Lab Med 2012;50:2093-105. Review.
19. van Kimmenade RR, Januzzi JL Jr, Baggish AL, Lainchbury JG, Bayes-Genis A, Richards AM, et al. Amino-terminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction? J Am Coll Cardiol 2006;48:1621-7.
20. McCullough PA, Kellum JA, Haase M, Müller C, Damman K, Murray PT, et al. Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013;182:82-98.
21. Haase M, Müller C, Damman K, Murray PT, Kellum JA, Ronco C, et al. Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013;182:99-116.
22. Tomlanovich S, Golbetz H, Perlroth M, Stinson E, Myers BD. Limitations of creatinine in quantifying the severity of cyclosporine-induced chronic nephropathy. Am J Kidney Dis 1986;8:332-7.
23. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992;38:1933-53. Review.
24. Waikar SS, Bonventre JV. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 2009;20:672-9.
25. Desai AS, Toto R, Jarolim P, Uno H, Eckardt KU, Kewalramani R, et al. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. Am J Kidney Dis 2011;58:717-28.
26. van Kimmenade RR, Pinto Y, Januzzi JL, Jr. When renal and cardiac insufficiencies intersect: is there a role for natriuretic peptide testing in the 'cardio-renal syndrome'? Eur Heart J 2007;28:2960-1.
27. Macdonald S, Arendts G, Nagree Y, Xu XF. Neutrophil gelatinase-associated lipocalin (NGAL) predicts renal injury in acute decompensated cardiac failure: a prospective observational study. BMC Cardiovasc Disord 2012;12:8.
28. Bhavsar NA, Kottgen A, Coresh J, Astor BC. Neutrophil gelati-nase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2012;60:233-40.
29. Breidthardt T, Socrates T, Drexler B, Noveanu M, Heinisch C, et al. Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure. Crit Care 2012;16:R2.